144 related articles for article (PubMed ID: 22466)
1. [The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)].
Hata S
Nihon Naibunpi Gakkai Zasshi; 1977 Oct; 53(10):1129-39. PubMed ID: 22466
[TBL] [Abstract][Full Text] [Related]
2. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F
Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876
[TBL] [Abstract][Full Text] [Related]
3. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
McKenna F; Davison AM
Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
[TBL] [Abstract][Full Text] [Related]
4. Effect of penbutolol on circadian blood pressure, and renin, aldosterone and cortisol levels in patients with essential hypertension.
degli Uberti EC; Portaluppi F; Margutti A; Trasforini G; Bianconi M; Teodori V; Rossi R; Pansini R
Acta Cardiol; 1988; 43(1):5-20. PubMed ID: 3287810
[TBL] [Abstract][Full Text] [Related]
5. Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study.
Obel AO
J Cardiovasc Pharmacol; 1989 Mar; 13(3):465-70. PubMed ID: 2471894
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
Salvetti A; Pedrinelli R; Simonini N
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
[TBL] [Abstract][Full Text] [Related]
7. The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents.
Stokes GS; Graham RM; Weber MA
Drugs; 1976; 11 SUPPL 1():150-6. PubMed ID: 6247
[TBL] [Abstract][Full Text] [Related]
8. beta-Adrenergic receptors and renin release: studies with beta-adrenoreceptor-blocking agents in the conscious rabbit.
Weber MA; Oates HF; Stokes GS
Clin Sci Mol Med Suppl; 1975 Jun; 2():89s-91s. PubMed ID: 28880
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
10. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
Browne GA; Griffin TP; O'Shea PM; Dennedy MC
Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
12. [Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone].
Grüninger U; Akert R; Hunkeler H; Wegmüller E; Weidmann P; Hodler J
Klin Wochenschr; 1979 Jul; 57(14):731-9. PubMed ID: 470335
[TBL] [Abstract][Full Text] [Related]
13. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension.
Reams GP; Bauer JH; Lau A
J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665
[TBL] [Abstract][Full Text] [Related]
14. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.
Rotmensch HH; Rocci ML; Vlasses PH; Swanson BN; Fedder IL; Soyka L; Ferguson RK
Am J Cardiol; 1984 Aug; 54(3):353-6. PubMed ID: 6147080
[TBL] [Abstract][Full Text] [Related]
15. Effects of carvedilol on renal function.
Dupont AG
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S96-100. PubMed ID: 1974513
[TBL] [Abstract][Full Text] [Related]
16. The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension.
Pedrinelli R; Arzilli F; Cavasinni L; Poli L; Sassano P; Salvetti A
J Endocrinol Invest; 1978 Oct; 1(4):315-20. PubMed ID: 756881
[TBL] [Abstract][Full Text] [Related]
17. [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)].
Lombardo M; Fusco M; Valente D
G Ital Cardiol; 1979; 9(12):1363-70. PubMed ID: 45015
[TBL] [Abstract][Full Text] [Related]
18. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.
Salvetti A; Arzilli F; Pedrinelli R; Beggi P; Motolese M
Eur J Clin Pharmacol; 1982; 22(3):197-201. PubMed ID: 7049707
[TBL] [Abstract][Full Text] [Related]
19. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
Weidmann P; Beretta-Piccoli C; Ziegler W; Hirsch D; de Châtel RD; Reubi FC
Klin Wochenschr; 1976 Aug; 54(16):765-73. PubMed ID: 8663
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effect of a beta receptor blockader, oxprenolol, in hypertension--its relationship with renin-aldosterone activities].
Kunida H; Hatake S; Okamoto M
Horumon To Rinsho; 1974 Sep; 22(9):1067-75. PubMed ID: 4609642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
